Phenotypic screening approach

Screen biology. Measure function.

From high-content cellular screening to functional human tissues, myrScreen connects scalable image-based assays with deeper physiological assessment.

High-content imaging

Functional tissue screening

2-tiered assessment

Two screening engines · one biological continuum

CELLULAR SCALE

High Content Screening

TISSUE SCALE

Functional Phenotypic Screening

Deeper biological insight

Two biological scales. One connected workflow.

Choose the level of biology that matches your question from scalable cellular phenotypes to functional 3D human tissue.

Cellular scale · High-Content screening

384-well HTS | Reporter Models
Reporter-enabled human iPSC models for image-based, high-content, high throughput, qualitative screening at scale.

See more. Screen more.

Tissue Scale · Functional physiological Screening

Engineered 3D human muscle for longitudinal functional screening and deeper physiological characterization

48-well myrPlate | myrImager – Longitudinal video-optical measurement
48-well myrPlate | myrImager – Longitudinal video-optical measurement
Organ Bath – End-point physiological validation

Screen broadly. Characterize deeply

Readouts

Longitudinal video-optical measurement

Beating rate
Passive tension
Contraction and relaxation kinetics
Force of contraction

Organ bath validation

Isometric force
Beating rate and rhythm
Contraction and relaxation kinetics

(positive/negative inotropy, lusitropy)

Force-length relationship

(preload/Frank-Starling)

Built around the biological question.

myrScreen supports multiple therapeutic modalities and study designs across discovery, efficacy and safety programmes.

Therapeutic modalities

Small molecules

AAV

siRNA

LNP

Study designs

Preventive

Therapeutic

CardioTox

Acute treatment

Chronic repeat treatment

Therapeutic index

Have a biological question?

Let‘s discuss the screen around the biology, the therapeutic modality and the decision you need to make.

myriamed offers a two-tiered phenotypic screening approach. This includes a primary screen in a proprietary 48-cell format followed by result verification using classical organ bath measurements under isometric conditions. Endpoints include force, beating rate and rhythm, contraction kinetics and many more. Please contact us for further details. The myrScreen strategy is adapted according to the specific needs of our customers.

myrScreen-Cardio

myrScreen-Cardio is a human  48-well platform that allows analyses of function and dysfunction as well as regeneration and degeneration in engineered human hearts.

For more information see also:
Defined Engineered Human Myocardium with Advanced Maturation for Applications in Heart Failure Modelling and Repair.

myrScreen-Skeletal

myrScreen-Skeletal allows the simultaneously analyses of function and dysfunction as well as regeneration and degeneration in 48 engineered human skeletal muscle models.

For more information see also:
Engineered skeletal muscle recapitulates human muscle development, regeneration and dystrophy.

myrScreen-Connective Tissue

myrScreen-Connective Tissue for stroma function and dysfunction screens including screens for antifibrotic drugs.

For more information see also:
Using different geometries to modulate the cardiac fibroblast phenotype and the biomechanical properties of engineered connective tissues.

myrScreen-Brain

myrScreen-Brain allows the simultaneously analyses of function and dysfunction as well as regeneration and degeneration assayed on multi-electrode arrays.

For more information see also:
Developmental GABA polarity switch and neuronal plasticity in Bioengineered Neuronal Organoids.

Copyright 2026 Seaside Media. All Rights Reserved.